Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization.
Agracetus, Inc., Middleton, Wisconsin 53562, USA.
J T
JT
Fuller
D H
DH
Fuller
D
D
McCabe
J R
JR
Haynes
G
G
Widera
D000818:Animals; D004274:DNA, Recombinant / Q000008:administration & dosage; D005822:Genetic Vectors / Q000008:administration & dosage*; D006183:H-2 Antigens / Q000235:genetics / Q000276:immunology; D006678:HIV / Q000235:genetics / Q000276:immunology; D000882:Haplorhini; D006510:Hepatitis B Antibodies / Q000096:biosynthesis* / Q000276:immunology; D006512:Hepatitis B Core Antigens / Q000235:genetics / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000235:genetics / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000276:immunology*; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology*; D007117:Immunization, Secondary; D007277:Injections, Jet; D051379:Mice; D008807:Mice, Inbred BALB C; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology*; D013045:Species Specificity; D013552:Swine; D014611:Vaccination / Q000295:instrumentation / Q000379:methods*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology*
D004274:DNA, Recombinant; D006183:H-2 Antigens; D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D016693:Receptors, Antigen, T-Cell, alpha-beta; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic